age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
87.06097
|
female
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 9,141
| 5,488.5938
| null | 10.5
|
white
| 18.796875
| 22
| 0.753906
| 0.611938
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
dnr after sadm
| 1
| 83
| 6.799805
| 60
| 20
| 36.09375
| 185.6875
| null | 0.199982
| 1.299805
| 142
| 7.269531
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,109
| 1
|
60.745
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null |
under $11k
| 9
| 14,478
| 4,920.8438
| null | 26
|
black
| 30.199219
| 29
| 0.622925
| 0.518921
| 1
| 0
| 0
|
yes
| 0.75
| 0.5
|
no dnr
| 9
| 42
| 11.199219
| 112
| 16
| 38.09375
| 524
| 2.799805
| 1.199951
| 1
| 144
| 7.399414
| null | null | null | null | 6
|
adl>=4 (>=5 if sur)
| 6
| 1,313
| 0
|
52.86499
|
female
| 0
| 11
|
Lung Cancer
|
Cancer
| 1
| 11
|
>$50k
| 0
| 20,940
| 11,508.2656
| null | 15.5
|
white
| 22.597656
| 11
| 0.615967
| 0.300964
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.3
|
dnr after sadm
| 3
| 80
| 15.798828
| 70
| 30
| 37.69531
| null | 2.899902
| 0.199982
| 0.799927
| 141
| null | null | null | null | 3
| 5
|
<2 mo. follow-up
| 5
| 23
| 1
|
69.04895
|
male
| 1
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 12
| null | 0
| 49,859
| 28,440.2969
| null | 34
|
white
| 31.5
| 52
| 0.587891
| 0.478943
| 6
| 1
| 0
|
no
| 0.6
| 0.55
|
dnr after sadm
| 11
| 63
| 8.699219
| 110
| 8
| 36.19531
| 130
| 2.899902
| 0.899902
| 8.099609
| 134
| 7.399414
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 12
| 1
|
66.31097
|
female
| 0
| 18
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 56,614
| 41,906.9375
| null | 22
|
white
| 23.097656
| 34
| 0.764893
| 0.626953
| 13
| 0
| 0
|
no
| 0.4
| 0.3
|
no dnr
| 18
| 62
| 7.5
| 69
| 24
| 36.79688
| 163.25
| 3.799805
| null | 3.099609
| 134
| 7.429688
| null | null | null | 4
| null |
no(M2 and SIP pres)
| 3.183199
| 92
| 1
|
71.86896
|
male
| 0
| 121
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 16
|
>$50k
| 0
| 195,312
| 104,546.312
| null | 28.5
|
white
| 29.296875
| 47
| 0.68689
| 0.594971
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 59
| 4
| 62
| 5
| 39.09375
| 195
| 2.199707
| 0.5
| 0.5
| 131
| 7.469727
| null | null | null | null | 5
|
no(M2 and SIP pres)
| 5
| 1,307
| 0
|
67.92096
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| 12,316
| 7,214.0312
| null | 14.5
|
white
| 19
| 20
| 0.825928
| 0.766968
| 1
| 0
| 0
|
yes
| 0.5
| 0.3
|
no dnr
| 9
| 77
| 22.199219
| 80
| 25
| 36.09375
| 367.5
| null | 1.199951
| 0.899902
| 141
| 7.479492
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 210
| 1
|
77.24298
|
male
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$25-$50k
| 0
| 4,298
| 2,533.3926
| null | 15
|
white
| 18.699219
| 17
| 0.775879
| 0.641968
| 1
| 0
| 0
|
yes
| 1
| 0.9
|
no dnr
| 4
| 87
| 12.398438
| 80
| 20
| 36.09375
| 395
| null | null | 1.699951
| 139
| 7.329102
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.838867
| 583
| 1
|
66.97095
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 8
|
under $11k
| 100
| 11,884
| 5,305.3516
| null | 14.5
|
black
| 35
| 50
| 0.054993
| 0.017998
| 1
| 1
| 0
|
yes
| 0.9
| 0.9
|
dnr before sadm
| -1
| 47
| 9.798828
| 98
| 11
| 36.29688
| 486.625
| 4.5
| 0.5
| 0.5
| 168
| 7.319336
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,305
| 0
|
31.05299
|
female
| 0
| 50
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 238,115
| 116,004.25
| null | 43.5
|
white
| 42
| 77
| 0.274963
| 0.166992
| 1
| 0
| 0
|
yes
| 0.7
| 0.5
|
no dnr
| 50
| 51
| 0.899902
| 134
| 12
| 38.29688
| 132
| 1.799805
| 1.799805
| 2
| 145
| 7.339844
| null | null | null | null | 3
|
adl>=4 (>=5 if sur)
| 3
| 1,305
| 0
|
63.452
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 0
| 30,733
| 10,592.25
| null | 31.5
|
white
| 29
| 34
| 0.671997
| 0.575928
| 7
| 0
| 0
|
no
| 0.97
| 0.98
|
no dnr
| 8
| 76
| 12.099609
| 104
| 32
| 39.29688
| 116.65625
| 2.799805
| null | 0.799927
| 132
| 7.459961
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 8
| 1
|
61.29999
|
male
| 1
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 0
| 148,632
| 93,047.125
| null | 58.333313
| null | 48.296875
| 69
| 0.181976
| 0.093994
| 4
| 0
| 0
|
no
| 0.25
| 0.2
|
dnr after sadm
| 19
| 50
| 39.296875
| 110
| 8
| 33.69531
| 61
| null | 3.299805
| 1.299805
| 132
| 7.349609
| null | null | null | null | null |
<2 mo. follow-up
| 2.48877
| 21
| 1
|
55.78897
|
male
| 0
| 16
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 19,538
| 11,818.8594
| null | 19.666656
| null | 22.699219
| 23
| 0.60498
| 0.287964
| 1
| 0
| 0
|
metastatic
| 0.15
| 0.05
|
no dnr
| 16
| 113
| 7.299805
| 96
| 32
| 38.69531
| 171.65625
| 3.099609
| 0.399963
| 1.099854
| 139
| 7.5
| null | null | null | null | null | null | 3.235352
| 82
| 1
|
87.25494
|
female
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
|
under $11k
| 9
| 16,061
| 10,449.7344
| 11,553.5859
| 19.5
|
white
| 20.597656
| 31
| 0.687988
| 0.520996
| 1
| 0
| 0
|
no
| 0.5
| 0.1
|
no dnr
| 10
| 67
| 8.599609
| 100
| 16
| 36.89844
| null | null | null | 1.199951
| 138
| null | null | 19
| 750
| null | 2
|
no(M2 and SIP pres)
| 2
| 348
| 1
|
46.30298
|
female
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 14,642
| 7,322.0742
| 2,511.67969
| 11
|
white
| 14.798828
| 5
| 0.785889
| 0.550903
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 4
| 73
| 13.5
| 105
| 23
| 38.19531
| 100
| null | null | 3.699707
| 127
| 7.389648
| null | 78
| 3,100
| null | null |
no(M2 and SIP pres)
| 2.73877
| 333
| 1
|
83.67096
|
female
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 12,886
| 2,669.707
| 9,251.5
| 24
|
white
| 26.398438
| 45
| 0.688965
| 0.596924
| 1
| 0
| 0
|
no
| 0.75
| 0.7
|
dnr after sadm
| 4
| 50
| 12.099609
| 105
| 16
| 36.09375
| null | 3.599609
| 1.199951
| 1.299805
| 125
| null | null | 39
| 5,180
| 1
| null |
<2 mo. follow-up
| 1.166748
| 4
| 1
|
49.69498
|
male
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 9
| null | 0
| 15,399
| 9,213.6016
| 9,007.91406
| 18.5
|
black
| 25.699219
| 51
| 0.832886
| 0.775879
| 1
| 0
| 0
|
no
| 0.95
| 0.92
|
no dnr
| 10
| 102
| 14.798828
| 130
| 30
| 39
| 155
| null | null | 0.5
| 130
| 7.5
| 147
| 13
| 1,530
| 0
| 0
|
SIP>=30
| 0
| 1,090
| 0
|
82.237
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 41,176
| 18,947.2656
| 25,436.6719
| 22
|
white
| 22.597656
| 29
| 0.678955
| 0.584961
| 3
| 0
| 0
|
yes
| 0.9
| 0.7
|
no dnr
| 14
| 68
| 0.799927
| 120
| 18
| 38.09375
| 152
| 2.099609
| 6.299805
| 2.5
| 127
| 7.289062
| 215
| 77
| 2,010
| 2
| 1
|
SIP>=30
| 1
| 245
| 1
|
74.40399
|
female
| 0
| 8
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 16
|
>$50k
| 0
| 12,160
| 6,177.9922
| 6,558.64844
| 10.5
|
white
| 14.298828
| 22
| 0.795898
| 0.671997
| 1
| 0
| 0
|
no
| 0.92
| 0.7
|
no dnr
| 8
| 63
| 21
| 124
| 36
| 36
| 319
| 2.699707
| 0.599976
| 1.199951
| 147
| 7.359375
| 226
| 44
| 1,027
| 3
| null |
no(M2 and SIP pres)
| 2.510742
| 805
| 1
|
85.224
|
male
| 1
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 6
| 20
|
>$50k
| 0
| 67,876
| 49,520.2188
| 45,099.1875
| 29.666656
|
white
| 24.199219
| 57
| 0.56897
| 0.457947
| 14
| 1
| 0
|
yes
| 0.3
| 0.3
|
dnr after sadm
| 4
| 81
| 9.599609
| 100
| 20
| 38.39844
| null | null | null | 0.799927
| 132
| null | 108
| 12
| 2,650
| null | 7
|
<2 mo. follow-up
| 7
| 14
| 1
|
87.60797
|
female
| 1
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 26
| 93,347
| 58,623.625
| 58,592.0625
| 15.25
|
white
| 23.796875
| 45
| 0.517944
| 0.401978
| 17
| 0
| 0
|
no
| 0.8
| 0.6
|
dnr after sadm
| 24
| 112
| 6.299805
| 115
| 10
| 35
| 230
| 2.399902
| 16.097656
| 1.799805
| 145
| 7.449219
| 296
| 34
| 1,494
| null | 1
|
<2 mo. follow-up
| 1
| 25
| 1
|
68.18896
|
female
| 0
| 37
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 14
|
under $11k
| 0
| 81,038
| 25,616.6562
| 67,540.75
| 25.25
|
white
| 28
| 20
| 0.733887
| 0.582886
| 1
| 0
| 0
|
no
| 0.75
| 0.7
|
no dnr
| 37
| 55
| 6.5
| 45
| 10
| 36.29688
| null | null | null | 0.399963
| 141
| null | null | 16
| 1,775
| null | 3
|
no(M2 and SIP pres)
| 3
| 1,088
| 0
|
58.46698
|
male
| 0
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| 19
|
>$50k
| 0
| 6,816
| 3,522.6035
| 4,406.54688
| 7
|
white
| 20.597656
| 40
| 0.790894
| 0.66394
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 5
| 79
| 11.699219
| 72
| 16
| 38
| null | null | 0.699951
| 0.899902
| 138
| null | null | null | 3,900
| 0
| 1
|
SIP>=30
| 1
| 1,088
| 0
|
72.62396
|
female
| 0
| 27
|
Lung Cancer
|
Cancer
| 3
| 8
|
under $11k
| 0
| 29,597
| 17,250.1875
| 23,536.5156
| 8.75
|
white
| 22.5
| 18
| 0.559937
| 0.237
| 1
| 0
| 0
|
metastatic
| 0.15
| 0.04
|
dnr after sadm
| 2
| 127
| 7.799805
| 130
| 52
| 38.5
| null | 2
| 0.899902
| 0.5
| 131
| null | 191
| 16
| 4,185
| null | 0
|
<2 mo. follow-up
| 0
| 37
| 1
|
85.05096
|
male
| 0
| 19
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 19
| null | 0
| 27,225
| 13,628.3281
| 17,693.3438
| 11
|
white
| 16.5
| 26
| 0.802979
| 0.681885
| 1
| 0
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 19
| 58
| 6
| 125
| 28
| 38.09375
| 150
| null | null | 1.399902
| 133
| 7.489258
| null | 28
| 3,400
| 2
| 0
|
no(M2 and SIP pres)
| 0
| 1,086
| 0
|
88.86798
|
female
| 0
| 5
|
Coma
|
Coma
| 0
| null | null | 94
| 4,313
| 2,654.1602
| 2,629.7793
| 6
|
white
| 19.398438
| 18
| 0.140991
| 0.090988
| 1
| 0
| 0
|
no
| 0.01
| 0.01
|
dnr before sadm
| -1
| 53
| 42.09375
| 75
| 12
| 38.89844
| 67
| null | 8.099609
| 5.5
| 155
| 7.419922
| 391
| 98
| null | null | null |
<2 mo. follow-up
| 3.016113
| 8
| 1
|
73.39899
|
male
| 0
| 3
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 5
| 10
|
under $11k
| 0
| 5,160
| 2,640.3477
| 2,933.28906
| 15
|
hispanic
| 22.699219
| 38
| 0.645996
| 0.46698
| 1
| 1
| 0
|
no
| 0.5
| 0.3
|
dnr after sadm
| 2
| 68
| 0.799927
| 120
| 24
| 38
| 297.125
| 2.399902
| 0.799927
| 2.099609
| 141
| 7.429688
| 74
| 21
| 4,070
| 3
| null |
adl>=4 (>=5 if sur)
| 2.510742
| 135
| 1
|
90.28296
|
male
| 1
| 5
|
Coma
|
Coma
| 1
| 8
|
under $11k
| 100
| 18,727
| 7,006.1328
| 13,303.1641
| 38
|
white
| 22
| 45
| 0.038994
| 0.018997
| 4
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 2
| 67
| 6.399414
| 46
| 22
| 36.89844
| 251
| null | null | 1.899902
| 137
| 7.439453
| 126
| 28
| 1,370
| null | null |
<2 mo. follow-up
| 3.491699
| 5
| 1
|
69.125
|
female
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 9
|
under $11k
| 0
| 8,771
| 4,925.7344
| 6,804.16797
| 6.5
|
black
| 19
| 9
| 0.855957
| 0.762939
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 9
| 93
| 6.5
| 80
| 20
| 36.09375
| null | null | null | 1
| 139
| null | 107
| 17
| 6,050
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,080
| 0
|
58.987
|
female
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| 16
|
$25-$50k
| 0
| 6,447
| 3,819.7754
| 3,711.09961
| 5
|
white
| 21.296875
| 23
| 0.764893
| 0.514893
| 1
| 0
| 0
|
metastatic
| 0.2
| 0.02
|
dnr after sadm
| 1
| 50
| 8.099609
| 50
| 28
| 38.09375
| 171.40625
| 4.399414
| 0.799927
| 1.399902
| 139
| 7.449219
| 109
| 27
| 440
| null | 3
|
<2 mo. follow-up
| 3
| 11
| 1
|
73.15796
|
female
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 16
|
under $11k
| 0
| 18,381
| 7,921.2852
| 9,295.98438
| 17.5
|
white
| 28.5
| 54
| 0.680908
| 0.511963
| 1
| 0
| 0
|
no
| 0.85
| 0.8
|
no dnr
| 11
| 107
| 11.099609
| 80
| 25
| 36.09375
| 375
| 2.5
| null | 8.099609
| 130
| 7.359375
| 191
| 69
| 110
| 2
| null |
SIP>=30
| 1.838867
| 679
| 1
|
93.04895
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 8
| null | 0
| 16,645
| 7,173.9883
| 11,388.4062
| 16.5
|
white
| 27.699219
| 43
| 0.487
| 0.368958
| 3
| 1
| 0
|
yes
| 0.9
| 0.75
|
no dnr
| 8
| 73
| 14.699219
| 72
| 20
| 35.79688
| 422.1875
| 3.299805
| null | 2.299805
| 142
| 7.429688
| 126
| 44
| 2,140
| 1
| 1
|
no(M2 and SIP pres)
| 1
| 1,078
| 0
|
62.31097
|
female
| 1
| 19
|
Coma
|
Coma
| 3
| 12
|
under $11k
| 100
| 47,340
| 29,971.7969
| 34,933.5312
| 30
|
black
| 27
| 45
| 0.093994
| 0.054993
| 1
| 1
| 0
|
yes
| 0.9
| 0.9
|
dnr after sadm
| 13
| 107
| 4.599609
| 80
| 20
| 36.79688
| null | 2.399902
| 1.5
| 0.799927
| 141
| null | 70
| 7
| 650
| null | 7
|
<2 mo. follow-up
| 7
| 19
| 1
|
78.87195
|
female
| 0
| 30
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 8
|
under $11k
| 0
| 63,298
| 26,520.2656
| 39,171.2188
| 23.25
|
white
| 28.699219
| 81
| 0.66394
| 0.566895
| 1
| 1
| 0
|
no
| 0.25
| 0.05
|
dnr after sadm
| 16
| 67
| 9.898438
| 70
| 8
| 35.89844
| 267.5
| 2.099609
| null | 5.299805
| 133
| 7.359375
| 163
| 97
| 39
| null | 6
|
<2 mo. follow-up
| 6
| 55
| 1
|
48.77798
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 2
| 12
| null | 0
| 7,376
| 3,867.5684
| 3,885.50977
| 13
|
white
| 24.5
| 11
| 0.582886
| 0.261963
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 5
| 63
| 12.398438
| 70
| 34
| 35.59375
| 315
| null | null | 1.899902
| 135
| 7.379883
| 258
| 90
| 775
| 3
| null |
SIP>=30
| 2.510742
| 150
| 1
|
75.15399
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
>$50k
| 0
| 51,018
| 25,412.875
| 31,865.5312
| 29
|
white
| 27.597656
| 35
| 0.635986
| 0.533936
| 8
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 11
| 53
| 11.099609
| 62
| 10
| 38.19531
| 410
| 2.799805
| 0.199982
| 0.699951
| 128
| 7.40918
| 96
| 14
| 2,820
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 300
| 1
|
95.33496
|
female
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null |
>$50k
| 0
| 18,790
| 8,041.3633
| 12,426.5391
| 25
|
white
| 20.097656
| 10
| 0.656982
| 0.480957
| 1
| 0
| 0
|
no
| 0.8
| 0.5
|
dnr after sadm
| 2
| 60
| 4.299805
| 80
| 15
| 36.69531
| null | 2.299805
| 7.699219
| 1
| 133
| null | 76
| 23
| 1,150
| null | 4
|
no(M2 and SIP pres)
| 4
| 1,053
| 1
|
43.44998
|
male
| 0
| 16
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 14
|
$25-$50k
| 0
| 67,444
| 43,043.2188
| 44,333.3125
| 38.333313
|
white
| 51.59375
| 83
| 0.007
| 0.001
| 8
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
no dnr
| 16
| 103
| null | 96
| 12
| 36.59375
| null | 3.299805
| 0.399963
| 0.599976
| 132
| null | 168
| 8
| null | null | 0
| null | 0
| 251
| 1
|
77.81494
|
male
| 1
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| null | null | 100
| 5,391
| 3,145.9785
| 3,294.9082
| 24
|
white
| 33.09375
| 79
| 0.090988
| 0.014999
| 1
| 0
| 1
|
no
| null | null |
dnr after sadm
| 3
| 100
| 14.599609
| 100
| 25
| 36.69531
| 323.75
| 3.899902
| null | 1.099854
| 140
| 7.329102
| 181
| 18
| 1,700
| null | null |
<2 mo. follow-up
| 6.068359
| 3
| 1
|
64.85394
|
male
| 1
| 14
|
MOSF w/Malig
|
ARF/MOSF
| 4
| 16
|
>$50k
| 0
| 57,305
| 20,685.6875
| 35,790.0938
| 27.666656
|
white
| 32.09375
| 55
| 0.452942
| 0.332947
| 3
| 0
| 0
|
yes
| 0.3
| 0.15
|
dnr after sadm
| 8
| 70
| 12.298828
| 100
| 30
| 39.39844
| null | null | null | 0.799927
| 139
| null | 143
| 11
| null | null | 1
|
<2 mo. follow-up
| 1
| 14
| 1
|
73.17999
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 0
| 15,118
| 8,541.5078
| 4,252.26953
| 11.5
|
white
| 23.597656
| 23
| 0.784912
| 0.714966
| 1
| 0
| 0
|
no
| 1
| 0.9
|
no dnr
| 9
| 67
| 11.5
| 100
| 20
| 36.09375
| 292
| 2.699707
| 0.799927
| 1.5
| 130
| 7.479492
| 305
| 49
| 935
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,072
| 0
|
77.24298
|
male
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 15
|
$25-$50k
| 0
| 9,213
| 4,534.9688
| 5,946.60938
| 9
|
white
| 20.699219
| 29
| 0.789917
| 0.662964
| 1
| 0
| 0
|
no
| 0.6
| 0.25
|
dnr before sadm
| 0
| 63
| 2.199707
| 60
| 15
| 40.29688
| 317.5
| 3.099609
| null | 2.5
| 145
| 7.479492
| 215
| 64
| 1,205
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,071
| 0
|
91.16797
|
female
| 1
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 14
|
$11-$25k
| 9
| 22,895
| 6,213.3398
| 20,997.8281
| 24.5
|
white
| 28.296875
| 33
| 0.44696
| 0.245972
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 6
| 67
| 6.599609
| 80
| 20
| 36.09375
| 173.3125
| null | null | 0.799927
| 136
| 7.259766
| 106
| 6
| null | null | 6
|
<2 mo. follow-up
| 6
| 11
| 1
|
45.10599
|
male
| 0
| 46
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
| null | 0
| 132,956
| 95,915
| 87,665.4375
| 41.5
|
white
| 19.296875
| 30
| 0.871948
| 0.826904
| 2
| 0
| 0
|
yes
| 0.5
| 0.5
|
no dnr
| 46
| 77
| 2.199707
| 130
| 20
| 36.09375
| null | null | null | 0.899902
| 135
| null | 99
| 4
| null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,071
| 0
|
73.61798
|
female
| 0
| 12
|
Lung Cancer
|
Cancer
| 4
| 14
|
$25-$50k
| 0
| 21,745
| 12,838.8906
| 13,445.8672
| 16
|
white
| 34.195313
| 30
| 0.218994
| 0.022999
| 1
| 0
| 0
|
metastatic
| 0.3
| 0.1
|
dnr after sadm
| 3
| 57
| 10
| 67
| 5
| 36.29688
| 210
| 2.799805
| 0.199982
| 0.699951
| 149
| 7.459961
| 162
| 14
| 501
| null | 4
| null | 4
| 67
| 1
|
87.45197
|
female
| 0
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 40,903
| 25,369.1562
| 27,328.6406
| 15.5
|
white
| 19.398438
| 43
| 0.771973
| 0.698975
| 3
| 1
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 27
| 53
| 5.799805
| 56
| 16
| 36.79688
| 362.9375
| 2.799805
| 0.299988
| 3.199707
| 137
| 7.379883
| 339
| 64
| 1,705
| null | 1
|
no(M2 and SIP pres)
| 1
| 1,068
| 0
|
72.10999
|
male
| 1
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 6
| null | null | 0
| 82,805
| 30,254.5
| 60,945.9375
| 46.666657
|
white
| 31.796875
| 43
| 0.527954
| 0.411987
| 15
| 1
| 1
|
no
| 0.5
| 0.4
|
dnr after sadm
| 14
| 50
| 13.5
| 68
| 30
| 36.09375
| 396.625
| null | 0.299988
| 1.5
| 150
| 7.389648
| 306
| 22
| 855
| null | null |
<2 mo. follow-up
| 5.959961
| 18
| 1
|
67.01196
|
male
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 13
|
$11-$25k
| 0
| 4,505
| 2,691.5371
| 2,555.98828
| 10
|
white
| 18.699219
| 24
| 0.789917
| 0.556885
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.3
|
no dnr
| 5
| 57
| 78.796875
| 67
| 11
| 35.69531
| 509.5
| 1.899902
| 0.399963
| 4.799805
| 138
| 7.329102
| 150
| 111
| 353
| 0
| 0
|
<2 mo. follow-up
| 0
| 27
| 1
|
67.258
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 4,037
| 2,270.6152
| 2,148.86914
| 15
|
white
| 21.296875
| 32
| 0.800903
| 0.678955
| 1
| 0
| 0
|
yes
| null | null |
no dnr
| 4
| 77
| 6.699219
| 80
| 20
| 39.39844
| null | 2.699707
| 0.5
| 0.599976
| 135
| null | 118
| 3
| null | 2
| 2
|
no(M2 and SIP pres)
| 2
| 99
| 1
|
63.59198
|
female
| 1
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 55,293
| 29,078.8281
| 36,228.8438
| 34
|
white
| 30.097656
| 47
| 0.710938
| 0.622925
| 1
| 0
| 0
|
no
| 0.7
| 0.7
|
dnr after sadm
| 11
| 63
| 11.199219
| 60
| 8
| 36.19531
| 116
| null | null | 1.399902
| 150
| 7.439453
| 158
| 43
| 3,081
| 0
| null |
<2 mo. follow-up
| 0.494751
| 12
| 1
|
38.81198
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 17
|
$25-$50k
| 0
| 46,577
| 28,459.8281
| 29,525.5
| 42
|
white
| 29.796875
| 54
| 0.79895
| 0.73291
| 2
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 9
| 111
| 7.5
| 50
| 8
| 35.79688
| 362.5
| null | null | 0.799927
| 146
| 7.379883
| 83
| 10
| 3,226
| null | 0
|
<2 mo. follow-up
| 0
| 10
| 1
|
72.03595
|
female
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 14
|
under $11k
| 0
| 18,033
| 10,641.3906
| 12,564.7188
| 18.5
|
white
| 21.097656
| 37
| 0.825928
| 0.716919
| 1
| 1
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 10
| 40
| 0.5
| 135
| 30
| 36.69531
| 110
| 1.5
| 3.699707
| 1
| 142
| 7.429688
| 156
| 30
| 2,810
| 5
| 1
|
SIP>=30
| 1
| 816
| 1
|
94.04199
|
female
| 0
| 13
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 0
| 12,115
| 7,034.9492
| 7,291.13672
| 6.5
|
white
| 15.5
| 51
| 0.758911
| 0.61792
| 1
| 0
| 0
|
no
| 0.2
| 0.05
|
dnr after sadm
| 1
| 43
| 6.599609
| 71
| 38
| 35.59375
| 309.5
| 3.699707
| 0.899902
| 2.5
| 137
| 7.419922
| 39
| 139
| 364
| 2
| 6
|
SIP>=30
| 6
| 74
| 1
|
58.29398
|
female
| 0
| 7
|
Lung Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 9,432
| 5,565.1484
| 6,786.11719
| 6.5
|
white
| 16
| 8
| 0.740967
| 0.475952
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.5
|
no dnr
| 7
| 52
| 3.399902
| 72
| 14
| 39.89844
| 95.70312
| 1.5
| 0.5
| 1.299805
| 142
| 7.469727
| 288
| 39
| 1,095
| 0
| null |
SIP>=30
| 0.494751
| 143
| 1
|
79.76996
|
male
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 11
|
$11-$25k
| 0
| 13,059
| 7,513.8086
| 8,096.76953
| 12
|
white
| 28.699219
| 43
| 0.658936
| 0.483948
| 1
| 0
| 0
|
no
| 0.8
| 0.2
|
dnr after sadm
| 1
| 63
| 3
| 50
| 25
| 37.5
| 352.375
| 4.399414
| 0.399963
| 1.399902
| 139
| 7.439453
| 86
| 11
| 1,025
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 224
| 1
|
93.5
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 17,669
| 7,677.5938
| 12,203.5156
| 17.5
|
white
| 23.097656
| 35
| 0.707886
| 0.619995
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 11
| 100
| 8.699219
| 100
| 20
| 36.09375
| 246
| 3.399902
| 0.399963
| 1.899902
| 137
| 7.269531
| 211
| 34
| 1,175
| null | null | null | 3.571289
| 1,059
| 0
|
64.98596
|
male
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 15,358
| 8,118.6953
| 8,780.17969
| 13
|
white
| 16.898438
| 34
| 0.892944
| 0.821899
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 11
| 63
| 10.898438
| 49
| 36
| 35.79688
| 215
| 2.5
| 0.5
| 1.099854
| 138
| 7.399414
| 122
| 24
| 2,900
| null | null | null | 3.209473
| 1,058
| 0
|
79.21997
|
male
| 1
| 13
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 26,546
| 19,413.3125
| 20,848.8906
| 23
|
white
| 21
| 46
| 0.718994
| 0.562988
| 1
| 0
| 0
|
yes
| 0.95
| 0.7
|
no dnr
| 13
| 60
| 12.5
| 130
| 8
| 38.5
| 276
| 2.299805
| 0.699951
| 1
| 144
| 7.439453
| 148
| 11
| 3,310
| null | 0
|
<2 mo. follow-up
| 0
| 13
| 1
|
73.16095
|
female
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 0
| 31,648
| 9,778.0625
| 27,422.9844
| 33
|
white
| 18.699219
| 34
| 0.767944
| 0.69397
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
dnr after sadm
| 1
| 69
| 10.398438
| 97
| 22
| 36.69531
| 148.5625
| 2.799805
| 0.299988
| 6.5
| 136
| 7.319336
| 82
| 37
| null | 2
| 6
|
adl>=4 (>=5 if sur)
| 6
| 71
| 1
|
64.53094
|
female
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| 6,520
| 3,431.6211
| 3,499.89844
| 15
|
white
| 16.597656
| 13
| 0.823975
| 0.618896
| 1
| 0
| 0
|
metastatic
| 0.79
| 0.25
|
no dnr
| 5
| 127
| 15.398438
| 70
| 30
| 37.89844
| 280
| 2.299805
| null | 0.699951
| 153
| 7.379883
| 299
| 31
| 2,035
| null | 0
|
<2 mo. follow-up
| 0
| 31
| 1
|
96.02496
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 0
|
$11-$25k
| 0
| 5,425
| 3,100.5625
| 3,094.23828
| 11
|
white
| 18.597656
| 16
| 0.768921
| 0.631958
| 1
| 0
| 0
|
no
| 0.8
| 0.5
|
no dnr
| 6
| 52
| 11.798828
| 63
| 10
| 38.59375
| 70
| 2.599609
| 0.5
| 1.599854
| 136
| 7.469727
| 270
| 35
| 2,215
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 153
| 1
|
79.61395
|
female
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 17
|
$11-$25k
| 0
| 49,723
| 19,671.1875
| 29,578.6094
| 33
|
white
| 26.796875
| 40
| 0.634888
| 0.532959
| 7
| 0
| 1
|
no
| 0.5
| 0.5
|
dnr after sadm
| 5
| 97
| 7.799805
| 80
| 20
| 36.69531
| null | 3.099609
| 1.699951
| 1.099854
| 138
| null | 88
| 23
| 300
| null | 1
|
<2 mo. follow-up
| 1
| 8
| 1
|
80.383
|
male
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 9
| 65,194
| 34,252.8438
| 40,685.7188
| 18
|
white
| 31.097656
| 49
| 0.445984
| 0.326965
| 16
| 0
| 0
|
no
| 0.2
| 0.2
|
no dnr
| 21
| 67
| 12
| 70
| 20
| 36.09375
| 280.9375
| 2.699707
| null | 1
| 139
| 7.519531
| 103
| 13
| 1,475
| null | null | null | 3.805176
| 71
| 1
|
72.82098
|
male
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
|
>$50k
| 0
| 9,040
| 2,867.6523
| 7,223.89844
| 42
|
white
| 37
| 77
| 0.402954
| 0.283997
| 1
| 0
| 0
|
yes
| 0.09
| 0.09
|
dnr after sadm
| 3
| 115
| 30.597656
| 130
| 38
| 36.69531
| 142.84375
| 3.199707
| 0.5
| 0.699951
| 145
| 7.479492
| 259
| 25
| 1,485
| null | null |
<2 mo. follow-up
| 2.372559
| 4
| 1
|
62.17899
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| null | null | 0
| 12,723
| 4,000.0977
| 7,637.37891
| 13.5
|
white
| 17
| 24
| 0.895996
| 0.825928
| 1
| 1
| 0
|
no
| 0.85
| 0.8
|
no dnr
| 7
| 69
| 14.099609
| 82
| 32
| 38.09375
| 71
| 2.299805
| null | 2.299805
| 136
| 7.389648
| 151
| 31
| 1,975
| null | null | null | 2.155273
| 840
| 1
|
91.59998
|
female
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| null | null | 9
| 6,892
| 3,620.3379
| 3,669.80859
| 19
|
white
| 23.199219
| 44
| 0.583984
| 0.390991
| 1
| 0
| 1
|
no
| 0.75
| 0.5
|
dnr before sadm
| -1
| 110
| 6.799805
| 80
| 24
| 38.09375
| 220
| 3
| 0.799927
| 6
| 140
| 7.329102
| 106
| 75
| 855
| null | null | null | 6.798828
| 1,051
| 0
|
63.70398
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 13
| null | 0
| 14,808
| 8,494.9297
| 9,352.98438
| 11.5
|
white
| 24.097656
| 25
| 0.823975
| 0.713989
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
dnr after sadm
| 3
| 70
| 11.798828
| 80
| 25
| 37
| 344
| 4
| 1.099854
| 1.5
| 134
| 7.549805
| 127
| 61
| 700
| 1
| null |
no(M2 and SIP pres)
| 1.166748
| 1,052
| 0
|
49.94098
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 6,022
| 3,451.0117
| 3,434.55859
| 9
|
white
| 13.798828
| 37
| 0.93689
| 0.892944
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 6
| 73
| 6.5
| 70
| 20
| 36.69531
| null | null | 0.5
| 0.5
| 139
| null | 101
| 12
| null | null | null | null | 2.330566
| 1,052
| 0
|
80.65698
|
female
| 1
| 16
|
Coma
|
Coma
| 1
| 12
|
under $11k
| 100
| 52,292
| 35,646.375
| 36,685.375
| 28.666656
|
white
| 31.296875
| 62
| 0.011999
| 0.004
| 1
| 1
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 13
| 107
| 6.599609
| 50
| 25
| 36.09375
| 186.1875
| null | null | 4.5
| 138
| 7.5
| 179
| 70
| 1,900
| null | 0
|
<2 mo. follow-up
| 0
| 16
| 1
|
73.185
|
male
| 0
| 13
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
>$50k
| 0
| 21,289
| 9,521.3359
| 9,611.84375
| 11
|
white
| 22.097656
| 22
| 0.795898
| 0.671997
| 1
| 0
| 0
|
no
| 0.8
| 0.5
|
dnr after sadm
| 2
| 58
| 14.099609
| 107
| 28
| 39.09375
| 330
| null | null | 0.799927
| 134
| 7.40918
| 252
| 16
| 1,500
| 0
| 0
|
<2 mo. follow-up
| 0
| 23
| 1
|
92.35297
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 18
|
$25-$50k
| 9
| 4,530
| 2,524.7617
| 2,891.37891
| 5
|
white
| 21.296875
| 44
| 0.643921
| 0.463989
| 1
| 0
| 0
|
yes
| 0.75
| 0.4
|
no dnr
| 5
| 77
| 15.298828
| 80
| 20
| 36.69531
| 200
| null | null | 1.099854
| 137
| 7.40918
| 169
| 26
| 1,250
| 4
| 3
|
no(M2 and SIP pres)
| 3
| 1,037
| 1
|
71.06897
|
female
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 9,867
| 5,391.0859
| 5,893.84766
| 11
|
white
| 15
| 11
| 0.886963
| 0.81189
| 1
| 0
| 1
|
no
| 0.99
| 0.98
|
no dnr
| 8
| 107
| 14.199219
| 110
| 26
| 36.5
| 313
| null | null | 1
| 137
| 7.429688
| 246
| 28
| 607
| null | null | null | 5.033203
| 1,048
| 0
|
70.69098
|
female
| 1
| 17
|
Colon Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| 15,326
| 9,194.1484
| 901.73975
| 7.333332
|
white
| 42
| 35
| 0.194977
| 0.016998
| 1
| 0
| 0
|
metastatic
| 0.3
| 0.1
|
dnr after sadm
| 3
| 58
| 11.699219
| 74
| 8
| 37.89844
| 180
| 3.399902
| null | 1.199951
| 142
| 7.389648
| 151
| 24
| 2,885
| null | 7
|
<2 mo. follow-up
| 7
| 17
| 1
|
81.45898
|
female
| 0
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 12
|
under $11k
| 0
| 38,340
| 16,256.4531
| 24,652.8594
| 22.666656
|
white
| 33.898438
| 37
| 0.516968
| 0.40094
| 1
| 1
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 24
| 78
| 12.199219
| 76
| 16
| 37.79688
| null | 3.199707
| 0.399963
| 1.099854
| 138
| null | 83
| 19
| null | 2
| 2
|
no(M2 and SIP pres)
| 2
| 541
| 1
|
56.85999
|
female
| 0
| 22
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 31,629
| 14,054.8281
| 22,525.2812
| 15.333328
|
white
| 29.5
| 40
| 0.787964
| 0.660889
| 1
| 0
| 0
|
no
| 0.75
| 0.6
|
no dnr
| 22
| 60
| 5.599609
| 80
| 20
| 36.09375
| null | null | null | 1.199951
| 129
| null | 109
| 18
| null | 4
| 1
|
no(M2 and SIP pres)
| 1
| 1,047
| 0
|
53.43698
|
female
| 1
| 4
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 4,094
| 2,367.0938
| 3,063.93945
| 11
|
white
| 40.796875
| 59
| 0.117996
| 0.004999
| 1
| 0
| 0
|
metastatic
| 0
| 0
|
dnr before sadm
| -1
| 65
| 16.597656
| 126
| 20
| 36.89844
| 140
| 2.199707
| 0.299988
| 0.899902
| 149
| 7.40918
| 265
| 35
| 2,447
| null | null |
<2 mo. follow-up
| 2.522949
| 4
| 1
|
34.72098
|
male
| 0
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 19
|
$11-$25k
| 0
| 8,854
| 3,487.0508
| 6,401.4375
| 24
|
white
| 12.798828
| 12
| 0.952881
| 0.935913
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 5
| 133
| 26.296875
| 134
| 22
| 36.09375
| 236.71875
| 3.399902
| 1.399902
| 4.5
| 147
| 7.389648
| 111
| 125
| 1,355
| null | null |
no(M2 and SIP pres)
| 1.622803
| 1,042
| 0
|
49.65399
|
female
| 0
| 32
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 13
| null | 0
| 45,260
| 21,936.75
| 27,900.5156
| 20.25
|
white
| 19.699219
| 32
| 0.866943
| 0.819946
| 1
| 1
| 0
|
yes
| 0.95
| 0.9
|
dnr after sadm
| 2
| 43
| 5.899414
| 111
| 15
| 38.59375
| 336
| 2.399902
| 1.199951
| 5.399414
| 151
| 7.389648
| 99
| 70
| 285
| null | 6
|
adl>=4 (>=5 if sur)
| 6
| 1,041
| 0
|
46.78198
|
male
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$25-$50k
| 0
| 7,958
| 4,409.9375
| 4,171.21875
| 5.5
|
hispanic
| 16.597656
| 18
| 0.942993
| 0.902954
| 1
| 0
| 0
|
no
| 0.98
| 0.96
|
no dnr
| 7
| 109
| 6.899414
| 65
| 20
| 36.59375
| 524
| null | null | 1.699951
| 139
| 7.509766
| 224
| 30
| 2,100
| 2
| 0
|
no(M2 and SIP pres)
| 0
| 993
| 1
|
63.836
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 17,745
| 8,744.4062
| 3,793.07812
| 12
| null | 7.699219
| 12
| 0.850952
| 0.670898
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 4
| 77
| 3.799805
| 80
| 25
| 35.59375
| null | 3.299805
| 1.599854
| 2.099609
| 138
| null | 92
| 53
| 825
| null | null | null | 2.276856
| 1,039
| 0
|
76.47894
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
|
>$50k
| 0
| 26,124
| 8,544.6719
| 19,490.6406
| 44
|
white
| 28.097656
| 48
| 0.620972
| 0.516968
| 1
| 0
| 0
|
yes
| 0.3
| 0.3
|
no dnr
| 8
| 110
| 16.398438
| 70
| 25
| 36.69531
| 180
| 3.299805
| null | 0.5
| 136
| 7.399414
| 167
| 17
| 1,590
| null | 0
|
<2 mo. follow-up
| 0
| 8
| 1
|
66.04498
|
female
| 0
| 76
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 0
| 162,830
| 148,262.375
| 135,075.75
| 38.25
|
white
| 45.296875
| 68
| 0.291992
| 0.181
| 1
| 0
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 76
| 70
| 6.5
| 80
| 25
| 36.69531
| 319
| 4.199219
| 1.199951
| 1.599854
| 134
| 7.529297
| 106
| 24
| 1,500
| null | null |
adl>=4 (>=5 if sur)
| 1.987793
| 1,038
| 0
|
65.487
|
male
| 0
| 24
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 14
| null | 0
| 40,260
| 22,924.5312
| 25,569.4375
| 19.666656
|
white
| 24.597656
| 42
| 0.803955
| 0.68396
| 1
| 0
| 0
|
no
| 0.3
| 0.2
|
dnr after sadm
| 17
| 47
| 16
| 70
| 10
| 40.19531
| 382
| 3.699707
| 2.5
| 2.199707
| 145
| 7.459961
| 219
| 60
| 1,072
| 0
| 1
|
SIP>=30
| 1
| 231
| 1
|
74.98999
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
>$50k
| 0
| 51,049
| 32,962.1562
| 32,872.0625
| 24.5
|
white
| 30.199219
| 48
| 0.590942
| 0.482971
| 5
| 0
| 0
|
no
| 0.5
| 0.45
|
no dnr
| 11
| 100
| 9.398438
| 100
| 30
| 36.09375
| 385.125
| 3.199707
| null | 0.699951
| 141
| 7.239258
| 155
| 19
| 775
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,034
| 0
|
71.00897
|
female
| 1
| 20
|
Coma
|
Coma
| 3
| 12
|
under $11k
| 100
| 24,582
| 16,148.7969
| 18,534.9219
| 20
|
white
| 21.5
| 21
| 0.21698
| 0.153992
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 1
| 57
| 27.796875
| 80
| 20
| 36.09375
| 252.375
| null | null | 1.099854
| 132
| 7.459961
| 90
| 30
| 1,100
| null | 6
|
<2 mo. follow-up
| 6
| 20
| 1
|
82.26099
|
male
| 0
| 38
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
| null | 0
| 79,617
| 28,075.9219
| 62,717.75
| 33.75
|
white
| 26.097656
| 61
| 0.636963
| 0.535889
| 1
| 0
| 0
|
yes
| 0.5
| 0.3
|
dnr after sadm
| 8
| 107
| 4.799805
| 100
| 20
| 36.09375
| 498.3125
| 3.899902
| 0.299988
| 0.899902
| 135
| 7.359375
| 90
| 18
| null | null | 3
|
adl>=4 (>=5 if sur)
| 3
| 397
| 1
|
77.06494
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 11
|
$11-$25k
| 0
| 4,731
| 2,831.1074
| 2,518.73828
| 16
|
white
| 13.099609
| 13
| 0.894897
| 0.823975
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 4
| 67
| 20.199219
| 90
| 20
| 36.5
| 404.75
| 3.799805
| 4.099609
| 1.799805
| 143
| 7.549805
| 89
| 44
| null | 7
| 3
|
no(M2 and SIP pres)
| 3
| 381
| 1
|
79.91498
|
male
| 1
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 0
| 35,208
| 28,682.25
| 28,319.8594
| 27.5
|
white
| 33.695313
| 61
| 0.463989
| 0.344971
| 5
| 1
| 0
|
no
| 0
| 0
|
dnr after sadm
| 3
| 41
| 15.398438
| 109
| 28
| 37.69531
| 436.625
| 3
| 0.599976
| 1.699951
| 138
| 7.369141
| 82
| 36
| 2,340
| null | null |
<2 mo. follow-up
| 3.675293
| 12
| 1
|
80.05499
|
female
| 0
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
| null | 0
| 63,531
| 30,828.3438
| 32,720.3906
| 19.25
|
white
| 12.099609
| 17
| 0.866943
| 0.819946
| 9
| 0
| 0
|
no
| 0.7
| 0.65
|
no dnr
| 27
| 51
| 17.5
| 84
| 29
| 36.29688
| 122.4375
| 3.699707
| null | 1.299805
| 136
| 7.359375
| 200
| 21
| 3,070
| null | 0
|
no(M2 and SIP pres)
| 0
| 1,033
| 0
|
72.25494
|
male
| 0
| 7
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 5,886
| 3,460.0781
| 4,167.5
| 5.5
|
black
| 19.296875
| 10
| 0.639893
| 0.33197
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 40
| 15.699219
| 144
| 4
| 37.19531
| 105
| null | null | 0.899902
| 141
| 7.289062
| 209
| 13
| null | null | null |
<2 mo. follow-up
| 3.14502
| 9
| 1
|
41.172
|
female
| 0
| 10
|
Colon Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 15,770
| 8,478.8047
| 7,881.73828
| 17.5
|
white
| 25.699219
| 44
| 0.72998
| 0.457947
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.25
|
dnr after sadm
| 6
| 63
| 7.599609
| 72
| 16
| 38.29688
| 305
| 3.399902
| 0.899902
| 0.699951
| 141
| 7.419922
| 107
| 15
| 4,640
| null | 2
|
<2 mo. follow-up
| 2
| 26
| 1
|
64.04395
|
male
| 0
| 3
|
Colon Cancer
|
Cancer
| 2
| 12
| null | 0
| 2,867
| 1,655.6846
| 1,640.67969
| null |
white
| 17.898438
| 32
| 0.806885
| 0.586914
| 1
| 1
| 0
|
metastatic
| 0.7
| 0.1
|
no dnr
| 3
| 109
| 7.099609
| 129
| 22
| 39.39844
| 246.65625
| null | 0.599976
| 1.199951
| 146
| 7.289062
| 418
| 23
| 3,230
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 129
| 1
|
30.29999
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 15
|
>$50k
| 0
| 47,058
| 21,754.5938
| 41,279.4062
| 16
|
black
| 34.796875
| 74
| 0.715942
| 0.629883
| 1
| 0
| 0
|
yes
| 0.85
| 0.75
|
no dnr
| 12
| 107
| 8.298828
| 110
| 20
| 37.79688
| 247.59375
| null | 0.899902
| 1.199951
| 141
| 7.399414
| 106
| 13
| null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,031
| 0
|
79.49896
|
female
| 0
| 5
|
Colon Cancer
|
Cancer
| 2
| 14
|
under $11k
| 0
| 6,147
| 3,362.3672
| 2,897.75977
| 9
|
white
| 30.097656
| 19
| 0.503906
| 0.18399
| 1
| 0
| 0
|
metastatic
| 0.3
| 0
|
dnr after sadm
| 1
| 77
| 6.899414
| 80
| 20
| 37
| null | 4
| 0.299988
| 0.899902
| 135
| null | 98
| 8
| 4,300
| null | null |
adl>=4 (>=5 if sur)
| 2.431152
| 83
| 1
|
83.00598
|
female
| 0
| 28
|
Coma
|
Coma
| 1
| null | null | 37
| 23,863
| 14,685.375
| 18,159.7344
| 6
|
white
| 15.398438
| 21
| 0.42395
| 0.349976
| 1
| 0
| 0
|
metastatic
| 0.1
| 0
|
dnr after sadm
| 1
| 67
| 26.296875
| 72
| 23
| 39.09375
| 123.32812
| 2.199707
| null | 2.899902
| 135
| 7.359375
| 147
| 63
| 2,535
| null | null |
<2 mo. follow-up
| 3.220215
| 48
| 1
|
75.21399
|
male
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 6
| 9
|
under $11k
| 0
| 14,546
| 5,461.0391
| 10,412.1562
| 24
|
white
| 38.09375
| 59
| 0.289978
| 0.179993
| 4
| 0
| 1
|
yes
| 0
| 0
|
dnr after sadm
| 1
| 40
| 15.5
| 110
| 50
| 38.19531
| 144
| null | 5.099609
| 0.699951
| 139
| 7.509766
| 113
| 16
| 778
| null | null |
<2 mo. follow-up
| 5.163086
| 4
| 1
|
62.09198
|
male
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 9
| 102,751
| 54,442.6875
| 56,633.5625
| 44
|
white
| 22.898438
| 43
| 0.746948
| 0.666992
| 16
| 0
| 0
|
no
| 0.3
| 0.25
|
no dnr
| 5
| 107
| 7.899414
| 100
| 20
| 35.59375
| 261.875
| 3.899902
| 1.399902
| 3.099609
| 132
| 7.5
| 89
| 45
| 1,650
| null | null |
<2 mo. follow-up
| 1.899658
| 5
| 1
|
80.24896
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 28,091
| 16,275.4766
| 18,633.5938
| 35
|
white
| 21.5
| 43
| 0.764893
| 0.688965
| 3
| 0
| 0
|
no
| 0.05
| 0.05
|
no dnr
| 6
| 127
| 14.199219
| 180
| 36
| 38.09375
| 138
| 2.899902
| null | 0.599976
| 134
| 7.5
| 173
| 9
| 2,540
| null | null |
<2 mo. follow-up
| 2.225098
| 6
| 1
|
86.38995
|
male
| 1
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 9
| 17,556
| 7,838.75
| 11,553.1641
| 33
|
white
| 26.296875
| 41
| 0.639893
| 0.53894
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 1
| 123
| 16.898438
| 120
| 24
| 38.5
| 240
| null | null | 0.699951
| 148
| 7.429688
| 121
| 13
| 810
| null | null |
<2 mo. follow-up
| 3.976074
| 9
| 1
|
91.25299
|
female
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 8
|
under $11k
| 0
| 12,313
| 7,960.0508
| 7,772.60938
| 35
|
white
| 26.699219
| 49
| 0.641968
| 0.540894
| 1
| 1
| 0
|
no
| 0.5
| 0.25
|
dnr after sadm
| 4
| 55
| 9.798828
| 120
| 6
| 38
| 218
| 2.199707
| null | 1.899902
| 148
| 7.40918
| 79
| 41
| 632
| null | null |
<2 mo. follow-up
| 3.506348
| 4
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.